Long-term methotrexate (MTX) treatment can cause MTX-related lymphoproliferative disorder (MTX-LPD). We experienced a case of MTX-LPD that was associated with severe osteonecrosis of the jaw mimicking medication-related osteonecrosis of the jaw. The patient was an 81-year-old woman with rheumatoid arthritis (RA) who was treated with MTX and bisphosphonate. After 7 years, she was referred to our department for the assessment of giant ulcer and exposure of the alveolar bone of the left maxilla. Histopathological and immunological analyses confirmed a diagnosis of MTX-LPD. At seven months after the cessation of MTX treatment, the ulcerative and necrotic lesions had markedly decreased in size. A 1-year follow-up examination showed no evidence of recurrence and good RA control.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849556PMC
http://dx.doi.org/10.2169/internalmedicine.8946-17DOI Listing

Publication Analysis

Top Keywords

osteonecrosis jaw
12
severe osteonecrosis
8
mtx treatment
8
oral methotrexate-related
4
methotrexate-related lymphoproliferative
4
lymphoproliferative disease
4
disease presenting
4
presenting severe
4
jaw case
4
case report
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!